» Authors » V Pozsgay

V Pozsgay

Explore the profile of V Pozsgay including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 189
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pozsgay V
Adv Carbohydr Chem Biochem . 2000 Oct; 56:153-99. PMID: 11039111
No abstract available.
2.
Pozsgay V
Org Lett . 2000 May; 1(3):477-9. PMID: 10822587
[formula: see text] In contrast to major advances in the chemical synthesis of oligosaccharides, the methods of purification of the intermediates are essentially the same as they were decades ago....
3.
Coxon B, Sari N, Batta G, Pozsgay V
Carbohydr Res . 2000 Mar; 324(1):53-65. PMID: 10723612
A synthetic octasaccharide fragment (2) of the O-specific polysaccharide (1) of Shigella dysenteriae type 1 has been studied as its methyl glycoside by one- and two-dimensional homo- and heteronuclear NMR...
4.
Toth A, MEDGYES A, Bajza I, Liptak A, Batta G, KONTROHR T, et al.
Bioorg Med Chem Lett . 2000 Jan; 10(1):19-21. PMID: 10636234
The chemical synthesis of the zwitterionic disaccharide 2 is described that corresponds to the repeating unit of the O-specific polysaccharide (1) of the gram-negative human pathogen Shigella sonnei. Passive hemolysis...
5.
Hajko J, Liptak A, Pozsgay V
Carbohydr Res . 1999 Dec; 321(1-2):116-20. PMID: 10612005
An efficient method for the synthesis of L-glucose from D-gulono-1,4-lactone via 1,2,3,4,5-penta-O-benzyl/acetyl/benzoyl-D-gulitol is described in 34-53% overall yield.
6.
Konadu E, Donohue-Rolfe A, Calderwood S, Pozsgay V, Shiloach J, Robbins J, et al.
Infect Immun . 1999 Oct; 67(11):6191-3. PMID: 10531288
Escherichia coli O157 is the major cause of diarrhea-associated hemolytic uremic syndrome (HUS). Strains causing HUS contain either Shiga toxin 1 (Stx1) or Stx2, or both. In adult volunteers, conjugate...
7.
Pozsgay V, Chu C, PANNELL L, Wolfe J, Robbins J, Schneerson R
Proc Natl Acad Sci U S A . 1999 Apr; 96(9):5194-7. PMID: 10220442
Our development of vaccines to prevent shigellosis is based on the hypothesis that a critical (protective) level of serum IgG to the O-specific polysaccharide (O-SP) domain of Shigella lipopolysaccharide (LPS)...
8.
Pozsgay V, Sari N, Coxon B
Carbohydr Res . 1998 Jul; 308(1-2):229-38. PMID: 9675362
Tri-, tetra-, and penta-saccharide fragments of the O-specific polysaccharide of Shigella dysenteriae type 1 have been prepared in which a D-galactose residue of each oligosaccharide methyl glycoside derivative contains a...
9.
Batta G, Liptak A, Schneerson R, Pozsgay V
Carbohydr Res . 1998 Apr; 305(1):93-9. PMID: 9534229
Complete assignments for the 1H- and the 13C-NMR spectra of the O-specific polysaccharide of S. sonnei/Plesiomonas shigelloides are reported. Evidence is presented that in this polysaccharide both pyranose residues exist...
10.
Miller C, Karpas A, Schneerson R, Huppi K, Kovac P, Pozsgay V, et al.
Mol Immunol . 1996 Nov; 33(16):1217-22. PMID: 9129157
Three murine, monoclonal antibodies, IgM 5286 F2, IgM 5297 C1, and IgG 5338 H4 were generated against Shigella dysenteriae type 1 O-specific polysaccharide (O-SP)-conjugate. They are specific for the O-SP,...